Delivery Order SPE2DB25D3020-SPE2DB25FWJPQ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of VAXNEUVANCE 0.5 ML syringes valued at $20,438.65 with a firm fixed price contract type. This order is expected to be completed by July 21, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was made through a competitive process with no set-aside designation, reflecting AmerisourceBergen's proven capability to meet federal...
- The Defense Logistics Agency awarded a $17,804.46 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Vaxneuvance 0.5 mL syringes. This is a firm fixed price, competitively awarded contract with an ultimate completion date of July 22, 2025, and will be performed in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,647.20 firm fixed-price contract is for the provision of VAXNEUVANCE 0.5 ML syringes, with an ultimate completion date of October 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,358.35 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion pharmaceutical supply vehicle that runs through December 2026. The delivery order is scheduled for completion by July 28, 2025, with performance...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,842.45 firm fixed-price delivery order is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of December 10, 2024. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA...
- This is a $13,630.64 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The delivery order has an ultimate completion date of July 16, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VAXNEUVANCE 0.5 mL syringes. The delivery order has a ceiling value of $6,142.64 and is set to expire on July 19, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
- This is a $35,815.44 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a medical product, with a completion date of June 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The contract has a ceiling value of $41,714.62 and a period of performance ending on March 27, 2025. This award is under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The contract has a firm fixed price of $3,042.88 and a completion date of May 15, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWJPQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Vaxneuvance 0.5 ML syringes, valued at $7,899.85. This firm fixed-price delivery order is scheduled for completion by July 22, 2025, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The award was competitively awarded without a set-aside designation, reflecting AmerisourceBergen's capability to meet federal pharmaceutical procurement requirements through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle, which encompasses specialty medications, vaccines, medical devices, and other essential healthcare commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 7/21/25 |